Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
PRA Health Sciences, Inc. (PRAH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/02/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/12/2021 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 07/12/2021 |
SC 13G
| INTEGRATED CORE STRATEGIES LLC reports a 0% stake in PRA HEALTH SCIENCES, INC. |
| 07/12/2021 |
SC 13G/A
| VANGUARD GROUP INC reports a 2.7% stake in PRA Health Sciences Inc. |
| 07/01/2021 |
4
| Gaenzle Christopher L (EVP, CAO & General Counsel) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Disposed/sold 34,500 shares
@ $0
Disposed/sold 37,500 options to buy
@ $101.42, valued at
$3.8M
Disposed/sold 16,666 options to buy
@ $95.94, valued at
$1.6M
Disposed/sold 17,114 options to buy
@ $103.3, valued at
$1.8M
Disposed/sold 5,647 restricted stock units
@ $0
Disposed/sold 14,008 restricted stock units
@ $0 |
|
| 07/01/2021 |
4
| SHANNON COLIN (President & CEO) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Disposed/sold 46,500 shares
@ $0
Disposed/sold 39,000 options to buy
@ $75.81, valued at
$3M
Disposed/sold 45,000 options to buy
@ $102.44, valued at
$4.6M
Disposed/sold 62,000 options to buy
@ $95.94, valued at
$5.9M
Disposed/sold 63,560 options to buy
@ $103.3, valued at
$6.6M
Disposed/sold 20,974 restricted stock units
@ $0
Disposed/sold 4,000 restricted stock units
@ $0
Disposed/sold 52,030 restricted stock units
@ $0 |
|
| 07/01/2021 |
4
| Bonello Michael J. (EVP & CFO) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Disposed/sold 4,480 shares
@ $0
Disposed/sold 6,000 options to buy
@ $75.81, valued at
$454.9k
Disposed/sold 20,000 options to buy
@ $81.61, valued at
$1.6M
Disposed/sold 16,666 options to buy
@ $95.94, valued at
$1.6M
Disposed/sold 17,114 options to buy
@ $103.3, valued at
$1.8M
Disposed/sold 5,647 restricted stock units
@ $0
Disposed/sold 2,000 restricted stock units
@ $0
Disposed/sold 14,008 restricted stock units
@ $0 |
|
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| Dickinson Alexander George (Director) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Disposed/sold 5,407 shares
@ $0 |
|
| 07/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/01/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/01/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/01/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/01/2021 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 07/01/2021 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 07/01/2021 |
8-K
| Quarterly results |
| 07/01/2021 |
8-K
| Quarterly results |
| 06/30/2021 |
4/A
| Bonello Michael J. (EVP & CFO) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Sold 6,589 shares
@ $166.43, valued at
$1.1M
Sold 600 shares
@ $167.47, valued at
$100.5k
Sold 195 shares
@ $168.19, valued at
$32.8k
|
|
| 06/30/2021 |
4/A
| SHANNON COLIN (President & CEO) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Sold 7,132 shares
@ $166.42, valued at
$1.2M
Sold 564 shares
@ $167.39, valued at
$94.4k
Sold 430 shares
@ $168.13, valued at
$72.3k
|
|
| 06/25/2021 |
8-K
| Quarterly results |
| 06/21/2021 |
4
| Gaenzle Christopher L (EVP, CAO & General Counsel) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Sold 1,300 shares
@ $167.4, valued at
$217.6k
Sold 13,391 shares
@ $168.06, valued at
$2.3M
Sold 12,114 shares
@ $169.41, valued at
$2.1M
Sold 692 shares
@ $169.75, valued at
$117.5k
Exercised 4,213 options to buy
@ $95.94, valued at
$404.2k
Exercised 18,958 options to buy
@ $101.42, valued at
$1.9M
Exercised 4,326 options to buy
@ $103.3, valued at
$446.9k
|
|
| 06/21/2021 |
4
| Bonello Michael J. (EVP & CFO) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Sold 200 shares
@ $166.7, valued at
$33.3k
Sold 24,389 shares
@ $168.17, valued at
$4.1M
Sold 22,587 shares
@ $169.05, valued at
$3.8M
Sold 5,375 shares
@ $169.67, valued at
$912k
Exercised 35,661 options to buy
@ $81.61, valued at
$2.9M
Exercised 8,334 options to buy
@ $95.94, valued at
$799.6k
Exercised 8,556 options to buy
@ $103.3, valued at
$883.8k
|
|
| 06/21/2021 |
4
| SHANNON COLIN (President & CEO) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Sold 920 shares
@ $166.89, valued at
$153.5k
Sold 161,352 shares
@ $168.13, valued at
$27.1M
Sold 220,195 shares
@ $169, valued at
$37.2M
Sold 59,774 shares
@ $169.63, valued at
$10.1M
Exercised 77,425 options to buy
@ $11.73, valued at
$908.2k
Exercised 166,036 options to buy
@ $11.73, valued at
$1.9M
Exercised 91,000 options to buy
@ $75.81, valued at
$6.9M
Exercised 31,000 options to buy
@ $95.94, valued at
$3M
Exercised 45,000 options to buy
@ $102.44, valued at
$4.6M
Exercised 31,780 options to buy
@ $103.3, valued at
$3.3M
|
|
| 06/17/2021 |
4
| Gaenzle Christopher L (EVP, CAO & General Counsel) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Sold 14,386 shares
@ $168.27, valued at
$2.4M
Sold 202 shares
@ $168.83, valued at
$34.1k
Sold 13,778 shares
@ $166.48, valued at
$2.3M
Sold 500 shares
@ $167.49, valued at
$83.7k
Exercised 8,698 options to buy
@ $101.42, valued at
$882.2k
Exercised 1,933 options to buy
@ $95.94, valued at
$185.5k
Exercised 1,984 options to buy
@ $103.3, valued at
$204.9k
Exercised 9,844 options to buy
@ $101.42, valued at
$998.4k
Exercised 2,188 options to buy
@ $95.94, valued at
$209.9k
Exercised 2,246 options to buy
@ $103.3, valued at
$232k
|
|
| 06/17/2021 |
4
| Bonello Michael J. (EVP & CFO) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Sold 30,279 shares
@ $168.27, valued at
$5.1M
Sold 847 shares
@ $168.8, valued at
$143k
Sold 16,316 shares
@ $166.41, valued at
$2.7M
Sold 900 shares
@ $167.49, valued at
$150.7k
Exercised 14,000 options to buy
@ $75.81, valued at
$1.1M
Exercised 7,123 options to buy
@ $81.61, valued at
$581.3k
Exercised 17,216 options to buy
@ $81.61, valued at
$1.4M
|
|
| 06/17/2021 |
4
| SHANNON COLIN (President & CEO) has filed a Form 4 on PRA Health Sciences, Inc.|
Txns:
| Sold 142,093 shares
@ $168.3, valued at
$23.9M
Sold 1,210 shares
@ $168.75, valued at
$204.2k
Sold 83,941 shares
@ $166.44, valued at
$14M
Sold 4,104 shares
@ $167.49, valued at
$687.4k
Exercised 132,986 options to buy
@ $11.73, valued at
$1.6M
Exercised 16,242 options to buy
@ $11.73, valued at
$190.5k
Exercised 71,803 options to buy
@ $11.73, valued at
$842.2k
|
|
| 06/16/2021 |
8-K
| Quarterly results |
| 06/15/2021 |
8-K
| Quarterly results |
| 06/14/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 06/14/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
|
|
|